Acadia Pharmaceuticals Reports Q3 Revenue of $342.3 Million
Q3 revenue was $342.3 million, versus the FactSet estimate of $332.6 million.
Related stories
Albemarle Q3 Net Income Swings to $296.76 Million Profit
Q3 2026 net sales rose 19% to $1.55 billion.
M impact | EQUITY | Nov 04, 2026, 10:11 PM UTC
MetLife Q3 Net Income Rises to $2.397 Billion
MetLife reported third-quarter 2026 net income of $2.397 billion, up from $896 million a year earlier, alongside revenue growth.
M impact | EQUITY | Nov 04, 2026, 10:11 PM UTC
Great Elm Group Q1 Revenue Drops on Property Sale Timing
Great Elm Group reported lower Q1 revenue, citing the timing of property sales.
M impact | EQUITY | Nov 04, 2026, 10:09 PM UTC
Vaxcyte Q3 Loss Smaller Than Estimates; Plans VAX-31 Filing in H1 2028
Vaxcyte reported a Q3 loss smaller than estimates and plans to file VAX-31 in the first half of 2028.
M impact | EQUITY | Nov 04, 2026, 10:09 PM UTC
Mercado Libre Q3 Revenue and Financial Income Rise 45% to $10.75 Billion
Mercado Libre reported third-quarter net revenue and financial income of $10.75 billion, up 45% year over year. Brazil delivered the strongest growth.
M impact | EQUITY | Nov 04, 2026, 10:09 PM UTC
Genworth Financial Posts Q3 Net Loss on Closed Block Weakness
Genworth Financial reported a third-quarter net loss, citing weakness in its Closed Block segment.
M impact | EQUITY | Nov 04, 2026, 10:08 PM UTC